The first two authors contributed equally to the work Metabolic syndrome (MetS) is a set of metabolic alterations including high levels of low-density lipoprotein (LDL), which increase the risk of cardiomyopathy often leading to surgery. Despite inducing myopathy, statins are widely used to lower LDL. Cardiopulmonary bypass (Cpb) causes oxidative stress and metabolic injury, altering mitochondrial expression (Grp75) and endoplasmic reticulum (Grp78) chaperones, apoptotic enzymes (Bcl2 family) and increasing cardiomyocyte lipidllipofuscin storage. We believe that cardiomyocytes from patients with MetS may be more sensitive to surgical stress, in particular after simvastatin therapy (MetS+Stat). The study group included ten patients with MetS, ten patients with Mets+Stat and ten healthy subjects. Myocardial biopsies were obtained both before and after-Cpb. Grp75, Grp78, Bax, Bcll, lipids, lipofuscin and fibrosis were evaluated by immunol histochemistry. MetS cardiomyocytes had higher Grp75, Bax, fibrosis and lipofuscin. MetS+Stat had lower Grp75 and higher Grp78 expressions, high Bax, fewer fibrosis and higher lipofuscin content. Cpb did not vary the fibrosis and lipidsllipofuscin content, although it influenced the chaperones and Bax expression in all groups. These changes were more profound in patients with MetS and even more so in patients with MetS+Stat. The results suggest that MetS and MetS+Stat cardiomyocytes were more highly stressed after-Cpb, Interestingly, simvastatin caused high stress even before-Cpb.
prevent cardiovascular events. Statins are the most commonly prescribed drugs to reduce low-density lipoprotein (LDL) and cholesterol levels (2) . Clinical results have shown that statins prevent the formation and progression of coronary artery atherosclerosis and also reduce both adverse cardiovascular events and the need for revascularization. However, statins also seem to be associated with adverse events, such as myopathy and other side effects.
It is well known that statins reduce LDL levels by inhibiting mevalonate synthesis which is a precursor of ubiquinone, an obligatory component of the mitochondrial electron transport chain fundamental for energy synthesis. As a result, statins may cause additional mitochondrial metabolic stress with symptoms and signs that could suggest statin withdrawal in genetically predisposed vulnerable individuals (3) .
Experimental data has confirmed this hypothesis. In vitro and clinical studies have shown that simvastatin enhances oxidized LDL toxicity in cells (4) and that about 20% of treated patient developed clinically adverse effect including muscle damaged (5) . Furthermore, much statin induced metabolic stress may be without any observable clinical symptoms. Recent data have shown that simvastatin induces myotube atrophy and cell loss associated with impaired mitochondrial functions and cellular apotosis primary human skeletal myotubes, suggesting that mitochondrial dysfunction may underlie human statin-induced myopathy (6) .
Cardiopulmonary bypass (Cpb) used for cardiosurgery operations causes severe metabolic and mechanical myocardial injury with the production of specific proteins generically called heat stress proteins (HSPs) in the cytoplasmic organelles such as mitochondria and endoplasmic reticulum (ER). HSPs act as molecular chaperones that facilitate proper organelle functioning aimed at reducing Cpbinduced ischemia-reperfusion myocardial damage (7) . Salient HSPs are: Grp75 (alias mot-2/mthsp70/ PBP74/mortalin), mainly expressed inside the mitochondria, and Grp78 (alias BiP), mainly localized inside the ER (8) . Moreover, Grp75 and Grp78 are associated with apoptotic processes, which modulate the expression ofBcl2 family pro-apoptotic enzymes, such as Bax (9) , Bcl-2, on the other hand, is one of the most important anti-apoptotic proteins of the same family (10) . Consequently, Grp75, Grp78 and Bax are used to quantify myocardial metabolic cellular stress and injury.
We believe that the cardiomyocytes of MetS patients may have a greater stress chaperone expression and lipofuscin/ceroid content and that chronic statin therapy could increase cellular stress. Furthermore, we have hypothesized that patients with MetS who need Cpb surgery, may be more sensitive to I/R injury, in particular if they have also taken statins. To investigate these hypotheses, we used an in vivo human model of cardiomyocyte stress in highly selected patients with MetS both before and after Cpb and with or without chronic simvastatin therapy.
MATERIALS AND METHODS

Patient population
This study was approved by the institutional ethics committees of the local health authority (A.S.L. Brescia, Italy, n. 5/2008) and all participants (adult males), gave their written informed consent before commencing the study. Patients with MetS (n = 20) with CAD and stable angina undergoing surgery for elective coronary artery bypass graft (CABG), were consecutively recruited at San Rocco Hospital. MetS and metabolic risks were defined according to the US National Cholesterol Education Program Adult Treatment Panel III guidelines and modified as recommended by the latest American Heart AssociationlNational Heart, Lung, and Blood Institute Scientific Statement (11) .
All patients with MetS were type 2 diabetic and treated with oral hypoglycemic, hypertensive under pharmacological treatment, were obese and nonsmokers. All patients had their glycemia and arterial pressure under control. Of these patients, ten had chronic hypercholesterolemia, successfully treated with first generation simvastatin (40 mg/day) for at least 2 years. These were nominated patients with MetS+Stat. Patient exclusion criteria were: a) reduced ejection fraction, b) previous myocardial infarct, c) enlargement or hypertrophy of cardiac chambers, d) concomitant valvular diseases, e) arrhythmia, and f) concomitant liver, endocrine, pulmonary, or kidney diseases, g) myopathy and/or basal CPK increase. All patients underwent multiple isolated aortocoronary bypass grafts (n =2-4) with internal mammary arteries and saphenous veins.
Because it was impossible to obtain heart samples from healthy subjects as controls, we used matched age subjects (n = 10) without MetS (No-MetS) as a comparison group. These were non-diabetic, non-smokers and non-obese, with coronary artery without coronarography documented atherosclerosis, who had undergone cardiac surgery for reasons other than CABG, such as aortic aneurism, valvular diseases or atrial myxoma. In this group, patients with reduced ejection fraction, enlargement or hypertrophy of cardiac chambers, arrhythmia, hypertension, metabolic or endocrine diseases such as diabetes, obesity, liver, pulmonary, or kidney diseases and/or myopathy or basal CPK increase were not used. The demographic and clinical data are shown in Table I .
Surgical procedure
Anesthesia and muscle relaxation was induced in all patients with propofol (2.0-2.5 mg/kg) and atracurium (0.08 mg/kg) respectively as previously described (12) . The aorta was cross-clamped and intermittent antegrade and retrograde warm blood cardioplegia was used as previously described (13) . The operations were all performed by the same surgeon.
Tissue samples
Tissue biopsy samples were sampled as previously described (12) . Immediately after the start of Cpb, but before cardioplegia (before-Cpb), a biopsy sample (approximately 15 mg wet weight) was obtained from the right atrium. After 40 to 55 minutes of cardioplegic arrest (after-Cpb), ten minutes after aortic cross-clamp release, another biopsy was taken as close as possible to the previous one. There were no clinical complications related to the sampling procedure. The biopsy material was immediately fixed in 4% formaldehyde and stored at 4°C for 24 h, then paraffin was added. The bioptic material for lipid storage analysis was immediately frozen in liquid nitrogen and stored at -80°C.
Histochemistry
Lipid and lipofuscin/ceroid quantification. Atrium samples were embedded in OCT compound (Tissue-tek; Sakura Finetek USA, Inc., Torrance, CA, USA) and frozen. Ten-micron cryo-sections of the tissue were stained with Oil-Red-O (Sigma-Aldrich, St. Louis, MO, USA) for lipid detection and counter-stained with hematoxylin and eosin (H&E). Histological examinations were conducted with optical microscope at 1OOx magnification and were peerreviewed. The cardiomyocytes containing anomalous nuclei (with irregular profiles, with bit signs and/or fragmented) were counted and expressed as a percentage of total cardiomyocytes. The lipofuscin/ceroid pigments were evaluated in H&E or by autofluorescence (14) at 100x magnification. The relative amount oflipids and/or pigment accumulation on each slide was evaluated using a four-point scale ranging from no lipofuscin to abundant lipofuscin (score 1= none/minimal; score 2 = mild; score 3 = moderate; score 4 = abundant) and was based on its appearance at low power (40 x ) and at high power (100 x ) (15) .
Collagen density andfibrosis. The collagen density and fibrosis were evaluated using a Sirius red staining method as previously described (16) . Briefly, the sections were deparaffinized, rehydrated in distilled water and immersed in 1% phosphomolybdic acid (Sigma-Aldrich) for 5 min and then covered with 0.1% (w/v) sirius red F3B (C.1.35780 Science Lab, Houston, TX, USA) in saturated picric acid solution for 1 h at room temperature. The sections were then washed in water and rapidly dehydrated, clarified in xylene and mounted. The sections were analyzed using a light microscope (Olympus BX50, Tokyo, Japan) under normal and polarized light, obtained through a polarizer filter (Olympus U-ANT, Tokyo, Japan) in order to analyze the initial collagen organization, and subsequently also the fibrosis. Under these conditions, various thicknesses of collagen fibers were colored in different ways. During tissue response to injury, fibronectin and type III collagen were synthesized in increasing amounts, whereas the major constituent in normal tissue was type I collagen. While the birefringent (anisotropic) color was more a measure of collagen fiber size than of collagen type, usually the thick and denser type I collagen fibers ranged from orange to red, whereas the thinner type III collagen fibers appeared from yellow to green (17) .
Immunohistochemistry
Paraffin sections were incubated overnight with primary anti-Grp78 (sc-1050), anti-Grp75 (sc-13967), and anti-Bax (sc-526) and anti-Bcl2 (sc-492) polyclonal antibodies from Santa Cruz Biotechnology Inc. (Santa Cruz Biotechnology, CA, USA) and diluted 1:100, with PBS. The sections were processed according to the manufacturer's protocols and visualized with a rabbit ABC-peroxidase staining system kit (Santa Cruz Biotechnology). To exclude incorrect interpretation of the immuno-staining due to endogenous biotin (18) , we also carried out experiments using the peroxidise-antiperoxidase detection system, but obtained similar results. Each set of experiments was made in triplicate, with each replication carried out under the same experimental conditions. To obtain double immunofluorescence staining, the sections were incubated simultaneously with anti-Grp75 and anti-Grp'Zd overnightat 4°C. Subsequently, the sections were incubated with appropriate fluorescent secondary antibodies (red fluorescent dye anti-goat Alexa-Fluor 543, and green fluorescent dye anti-rabbit Alexa Fluor 488 from Invitrogen, Carlsbad, CA, USA) diluted in PBS 1:200. Finally, the samples were counterstained with DAPI, mounted and observed with a confocal microscope (LSM 510 Zeiss, Germany) at a final magnification of 40x. The immunohistochemistry control was performed by omitting the primary antibody in the presence of isotype-matchedIgGs.
The staining intensity on both histochemical and immunohistochemical slides was evaluated using an optical Olympus BX50 microscope equipped with an image analysis program (Image Pro Plus 4.5.1, Immagini e Computer, Milano, Italy) and analyzed quantitatively. The integrated optical density (laD) was calculated for arbitrary areas, by measuring 10 fields for each sample using a 20x lens.
Statistical analysis
Data are expressed as mean ±SD.A statistical analysis, one-way ANOVA followed by the Student-Newman-Keuls test or with a Student t-test, was also applied to compare the results of the different experimental groups. A value ofp<O.05 was considered statistically significant.
RESULTS
The IOD values of each antibody staining in all groups, both before and after Cpb are shown in 1. The graphs show that Cpb influenced, sometimes considerably, the expression of chaperones in all groups (Fig. I, A and B) , whereas the pro-apoptotic enzyme (Bax) increased mainly in patients with MetS ( Fig. IC) . It is interesting to note that the increase of Grp78 was accompanied by simultaneous increases ofBax staining and reduced Grp75 before and after-Cpb. The anti-apoptotic Bel2 was less marked in patients with MetS and much lower in patients with MetS+Stat before Cpb and did not vary significantly after-Cpb. However, we did note a slight increase of Bel2 staining after Cpb in patients with Mets+Stat ( Fig. ID) while the Bax/Bel2 ratio remained high ( Fig. IE) . After Cpb, the ratio Bax/Bel2 increased considerably in patients with MetS only (Fig. IE) . Furthermore, it should be considered that patients with MetS+Stat had significantly altered expressions of apoptotic enzymes even before-Cpb, with a very high Bax/Bel2 ratio that did not change after-Cpb ( Fig. IE) . Therefore, patients with MetS+Stat may have been more susceptible to post-ischaemic damage than patients with MetS. 
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Values are mean ± SD. ACE: angiotensin-converting enzyme. *p<O.OOI Histochemical and morphological analysis of waste bodies near the nucleus pole was most . consistent with that for lipofuscin/ceroids-like pigments (Fig. 2) . Indeed, after xylene extraction, Oil-red-O stain was faintly positive or not detectable (data not shown); whereas with H&E staining they appeared as yellow/brown pigmented bodies and were strongly auto-fluorescence .
Patients without MetS (No-MetS).
Before Cpb. The cardiomyocytes had elongate oval regular shaped nuclei, with mild to moderate (score 1/2) features of lipofuscin/ceroid pigments near the poles of the nuclei (Fig. 2, A and D) . The anomalous nuclei, with bit signs and/or irregular shape were about 7.6±2.5%. Fibrosis was very scarce (IOD: 2.6±0.3) with a prevalence of thin green fibres (Fig.   3A ). The cells had weak and occasionally moderate Grp75 staining of granular appearance, and were not uniformly distributed inside the cytoplasm but mainly expressed in the perinuclear cytoplasm (Fig.  4A ). The Grp78 immunofluorescence was weak and occasionally concentrated near the nucleus and at the periphery of cells (Fig. 4G ). The two chaperones co-localized evenly (bright yellow color) only inside the perinuclear cytoplasm of certain cells (Fig. 40) . Furthermore, we observed a close correspondence between co-localized areas of stress chaperones, Oilred-O, H&E and auto-fluorescence staining of debris products at opposite poles of the nuclei (Fig. 5, A-D) .
The Bax and Bcl2 staining were weak and the ratio Bax/Bcl2 were balanced between the two enzymes ( Fig. IE) .
After Cpb. The amount of fibrosis, lipofuscin and
No-MetS
G. CORSETTI ET AL. the nuclear shape did not change (data not shown). The cardiomyocytes showed moderate and diffuse Grp75 staining ( Fig. 4B) and occasionally isolated or clustered cells had more intense staining. The Grp78 staining was moderate and distributed more uniformly inside the cells (Fig. 4H) . The chaperones co-localized as before Cpb (Fig. 4P ). Bax staining was weak inside the peri-nuclear cytoplasm of some cardiomyocytes .
MetS MetS+Stat
No-MetS MetS MetS+Stat
Bcl2 did not change significantly and the ratio Bax/ Bcl2 was less than one, indicating the prevalence of anti-apoptotic Bcl2 enzyme (Fig. IE) 
Grp75 (A-F). Before-Cpb (A, C, E), No-MetS cardiomyocytes had moderate Grp75 fluorescence (A). On the contrary, MetS and particularly MetS+Stat cells had only faint or very faint fluorescence (C and E). After-Cpb (B, D, F) the fluorescence increased in all groups, but its expression in patients with MetS and MetS+Stat remained lower than in No-Mets patients. Grp78 (G-N) . Before-Cpb (G, I, M) the cardiomyocytes from patients without MetS (No-MetS) and patients with MetS hadfaint or very faintfluorescence (G and I), whereas the MetS+Stat cells had very intensefluorescence (M). After-Cpb (H, L, N) the fluorescence increased moderately in the No-MetS group (H), much more in patients with MetS (L) and in patients with MetS+Stat the expression remained very high (N). Merge (O-T). Co-localization of Grp75 (red) and
Grp78 (green) antibodies before-(0, Q, S) and after-Cpb (P, R, T) by double stain immuno-fluorescence. Bright yellow indicates detection ofapproximately equal amounts ofGrp75 and Grp78, whereas yellow/green to yellow/orange indicate unbalanced amounts ofantibodies. Subjects without MetS (No-MetS group) had a prevalence ofGrp75 staining and so staining was dark red/orange both before and after-Cpb (0 and P). Patients with MetS before-Cpb had a preponderance ofred (Q), whereas after-Cpb more green staining was evident (R). On the other hand, patients with MetS+Stat clearly had very high Grp78 expressions both before-(S) and after-Cpb (T). Equal amounts of two chaperones were evident (bright yellow) near the nucleus. Scale bar 100 um . were located inside the cytoplasm mainly near the nucleus (Fig. 2, B and E) . We observed a moderate to intense degree of fibrosis (100: 27.4±3.7) with a prevalence of orange-red fibres (Fig. 3B ). The Grp75 staining was moderate and found between the myofibrils forming a network shape inside perinuclear areas (Fig. 4C) . The Grp78 staining was very weak (Fig. 41) . The co-localization of two chaperones was evident only near the opposite pole of the nucleus of certain cells (Fig. 4Q) and also corresponded to lipofuscin/ceroid location. Bax and Bcl2 staining was weak and occasionally some cells were moderately stained (data not shown). The Bax/ Bcl2 ratio was higher indicating a slight prevalence ofBax (Fig. IE) . After Cpb. The degree of fibrosis, lipofuscin and the number of anomalous nuclei did not change significantly. The intensity of Grp75 and Grp78 staining did however increase significantly (Fig. 4 , D and L, respectively). The chaperones co-localized mainly around the nucleus (Fig. 4R) . Bax staining increased significantly in all cardiomyocytes and frequently certain cardiac cells had strong staining. Bcl2 expression decreased but not significantly, so the BaxlBcl2 ratio was much higher (Fig. IE) .
Patients with MetS+Stat.
Before Cpb. The nucleus ofmany cells (15.9±3.2%, p>O.OI vs No-MetS and MetS) was shortened and dilated and often seemed to have been bitten at one end. A lot oflarge pigment bodies (score 4) were seen around the nucleus, in particular near the poles (Fig.  2 , C and F). Fibrosis was evident with a prevalence of orange-red fibers, but was less than in patients with MetS nor» 14.73±2.1) ( Fig. 3C ). Cardiomyocytes had very weak Grp75 immuno-staining ( Fig. 4E ). On the contrary, we observed strong and diffuse Grp78 staining mainly concentrated inside perinuclear cytoplasm (Fig. 4M) . The chaperones co-localized exclusively at opposite poles of nuclei (Fig. 4S) . Bax were intensely expressed in all cells. Bcl2 were weakly expressed although some isolated cells were moderately expressed. The BaxlBcl2 ratio was very high (Fig. IE) .
After Cpb. The degree of fibrosis, lipofuscin content and the percentage of anomalous nuclei did not change significantly. Cardiomyocytes had more intense Grp75 (Fig. 4F) and Grp78 (Fig. 4N) staining mainly near the nucleus. The balanced co-localization of both antibodies were observed near nucleus poles (Fig. 4T ). Bax did not change whereas Bcl2 staining increasedonly moderately. Nevertheless,the BaxlBcl2 ratio was higher without any significant differences from before-Cpb (Fig. IE) .
DISCUSSION
This study demonstrates for the first time that MetS induces heavy morphologic and enzymatic changes in human cardiomyocytes, which in turn influences stress chaperones synthesis, activation of pro-apoptotic molecules and accumulation of lipofuscin/ceroid pigments in particular after-Cpb with warm intermittent blood cardioplegia. In addition, we demonstrated that long-term therapy with simvastatin (first generation statin), strongly induces cardiomyocyte stress even before-Cpb, suggesting impaired cardiomyocyte metabolism without any sign or symptoms of myopathy and/or other evidence of statin-related adverse effects.
We observed that patients with No-MetS and with MetS had moderate Grp75 staining distributed inside the cytoplasm cardiomyocytes. Grp75 is an essential protein belonging to the Hsp70 family of chaperones expressed in all cell types and tissues examined to date. Grp 75 is found in multiple subcellular sites although it resides predominantly in the mitochondria and performs multiple functions including mitochondrial biogenesis, mitochondrial import, intracellular trafficking, receptor internalization and inactivation of tumour suppressor protein p53 (19) .
Our results agree with previous work showing that Gpr75 can be found in more cell sites independent of their activity and/or metabolic role (20) . Interestingly, our patients with MetS+Stat had very low Grp75 before-Cpb. However, some intense staining was seen mainly inside the small cytoplasmic area near the nucleus. This would suggest less protection against mitochondrial dysfunction and metabolic stress before ischemia-reperfusion (IIR) injury. After-Cpb, Grp75 staining increased in all groups. In patients with MetS+Stat, Cpb only moderately increased the Grp75 staining and these patients had lower Grp75 staining than other groups, concentrated in small cytoplasmic areas. This suggests that these patients are less protected from IIR stress.
Indeed, a recent study showed that Grp75 over-expression protects against mitochondrial dysfunction, oxidative stress and cell death (21) (22) (23) . More recently, Grp75 over-expression has been shown to significantly reverse the increase of the Bax/Bel-2 ratio, suggesting that Grp75 can maintain the balance between anti-apoptotic and proapoptotic signals (10) . In line with these authors, we observed that patients with MetS and considerably more so those with MetS+Stat, had significantly stronger BaxlBel2 increases particularly after-Cpb, suggesting a possible dangerous effect of both MetS and simvastatin. Our data agree with previous experimental and human studies. Indeed, simvastatin causes a decrease in mitochondrial respiration in primary mouse myocytes and induces myotube atrophy and cell loss associated with impaired mitochondrial respiratory capacity, mitochondrial oxidative stress and apoptosis in primary human skeletal myotubes (24) .
Furthermore, we also found increased Grp 78, which is related to ER metabolism. Patients with MetS+Stat had higher Gpr78 expression before-Cpb, which was almost twice those of the other groups. This is indicative of chronic ER stress induced by the drugs. After-Cpb, Grp78 expression increased in all groups. However, the increase was higher in patients with MetS and MetS+Stat and was concomitant with pro-apoptotic Bax staining. This result agrees with previous work which shows that prolonged and/or massive ER stress stimulates apoptotic processes in cardiomyocytes (9, 25, 26) . As a result, we can say that the pro-apoptotic aspects of IIR injury were activated by prolonged mitochondrial and ER stress and could be heavily influenced not only by MetS per se, but more dramatically by chronic simvastatin therapy.
Increased cardiomyocyte stress activates intracellular signalling molecules in a similar way to pressure-overload, thus provoking the transcriptional machinery inducing hypertrophy and fibrosis (27) . Our results showed greater fibrosis in patients with MetS. However, the fibrosis decreases in simvastatintreated patients, suggesting that fibrosis is potentially reversible. These data on humans confirm those observed in an experimental study showing that simvastatin (5 mg/kg/day for 12 weeks) induces hypertrophy and fibrosis regression in transgenic hypertrophic cardiomyopathy rabbit models (27) .
We found that pro-apoptotic Bax expression is already high in simvastatin-treated patients before Cpb and after I/R insult in all our groups. Probably, the mitochondrial metabolic stress, shown as an alteration of the chaperones present, induced Bax expression in patients with MetS+Stat. However, Bax is upstream of caspase-3, which is a key promoter of apoptosis (28, 29) . Interestingly, Bax staining before-Cpb was significantly greater in patients with MetS+Stat, suggesting that statin-induced apoptosis may be mediated by a change of the Bax/ Bel2 signalling pathway. This would explain the large number of dilated, irregular and/or fragmented nuelei mainly observed in patients with Met+Stat.
Curiously, we also observed moderate increases of antiapoptotic Bel2 after-Cpb in patients with MetS+Stat. This was perhaps a cardiomyocyte attempt to protect itself against statin-induced death. However, the BaxlBel2 ratio remained high suggesting that simvastatin-induced apoptosis may be mediated by alteration of the BaxIBcl2 signalling pathway. However, after-Cpb Bax increased both in patients with MetS and MetS+Stat. Increased Bax after Cpb may alter mitochondrial permeability transition pore opening and so increase cytochrome-c release, apoptosome formation, and subsequent caspase-9 and caspase-3 activation, promoting further DNA fragmentation and cell death (28) (29) (30) . We also observed moderate increases of anti-apoptotic Bc12 in the statin-treated patients. This may have been an attempt by the cardiomyocytes to protect themselves against statin-induced death. However, the ratio Bax/ Bel2 again remained high. These data would suggest that first generation statins make cardiomyocytes more vulnerable to apoptosis even before Cpb.
The difference between cardiomyocyte immunostaining observed before and after Cpb suggest fast induction of stress and apoptotic enzymes. It is therefore logical to think that responses to stress stimuli could have involved protective mechanisms that otherwise required only a very short activation time and so the cell would have quickly died. Our observations agree with previous findings on this point. It is know that cold cardioplegia is a potent stimulus for induction of early immediate genes in the heart (31, 32) .
In addition, around the nucleus of all groups we also found Oil red-O stained bodies, autofluorescent bodies and H&E stained pigments inside the cardiomyocytes. These pigments were probably lipofuscin/ceroid. Although both ceroid and lipofuscin have the same principal origin, lipofuscin is considered to be the typical pigment of postmitotic cells, while ceroid accumulates as a result of pathological and experimental processes (33) . Lipofuscin/ceroid is often described as a wear-and-tear pigment, suggesting association with autophagic processes leading to cell damage. These pigments are composed of a mixed complex of breakdown products from free radical-induced lipid oxidation of cellular debris, together with proteins. In our opinion, the larger amounts of lipofuscin/ceroid pigments observed in MetS and much more in MetS+Stat patients, with concomitant irregular and/or fragmented nuclei, could reflect the considerable impairment of the metabolic activity of cardiomyocytes.
Recent clinical studies apparently disagree with this data. Sun et al. (34) demonstrated that atorvastatin initiated one week before the scheduled CABG with Cpb and continued in the postoperative period significantly decreased atrial fibrillation and inflammation in humans. However, their experimental protocol was very different from ours. It is important to remember that our patients were highly selected, all diabetic and obese and had received first generation statin therapy for over two years prior to surgery. We therefore cannot exclude the possibility that a short period of new generation statin administration before cardio-surgery could be advantageous for the myocardium after cardioplegia.
In conclusion, patients with MetS had significant metabolic stress after-Cpb which led to activation of pro-apoptotic phenomena, particularly if they had been treated for a long period with simvastatin therapy prior to surgery. This damage was mediated by stress chaperone regulation and the expression of pro-apoptotic enzymes. Interestingly, simvastatin chronic treatment caused metabolic cellular stress in all patients even before-Cpb. However, the fact that cellular simvastatin-mediate-damage can become clinically evident in genetically predisposed patients has recently been demonstrated (35) . We believe that these preliminary observations are important for health and surgical management of patients with MetS. In addition, recognition of the potentially adverse effects of statins with accurate risk-effect evaluation is important for implementing personalized therapy.
Study Limitations. Firstly, we sampled atrial rather than ventricular tissue. The reason for this was because our previous study showed the relation after-Cpb with atrial metabolic abnormities and ventricular function (12) . Secondly,only a limited number ofpatients were enrolled in this study. These patients were, however, highly selected to avoid any possible interference with our analysis. We are conscious that in the future more patients are needed to confirm our results. Thirdly, it is not clear from our work whether changes of mitochondrial and ER chaperone expression were protective or damagingper se. To answer this question it would be necessary to take some heart samples from the same patients several hours or days after surgery which is obviously impossible. Finally, we did not measure myocardial mechanical performance after Cpb. However, many studies have shown that metabolic stress with mitochondrial impairment with reactive oxygen species formation are concomitant with myocardial contractile dysfunction after-Cpb. We hope that these preliminary results will open a discussion on the need to optimize cardiac protection during Cpb in patients with MetS and analyze the riskbenefit of therapy for each patient, also considering the drugs used. This approach is a fundamental step for any personalized therapy.
